Mycotoxins are secondary metabolites produced by toxigenic fungus that contaminate raw materials and feedstuffs worldwide. They are considered an important risk for animal health. In fact, mycotoxins disrupt the gut barrier, leading to bacterial translocation and subsequent negative effects by the endotoxins (lipopolysaccharides, LPS).
The aim of the present study was to evaluate the in vitro efficacy of an anti-mycotoxins agent that contains selected binding
material and natural extracts besides an exclusive combination of yeasts, against the most important mycotoxins,
and endotoxins from Escherichia coli and Salmonella.
MATERIALS AND METHODS
The anti-mycotoxins agent tested in the present study has a high in vitro efficacy against a wide spectrum of mycotoxins, including T-2 mycotoxin from trichothecenes group, and endotoxins from E. coli O111:B4 and Salmonella Typhimurium.